UPDATE HealthEase/Staywell Medicaid Preferred Drug List April 3, 2014 Dear Provider: At the February 27, 2014 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the HealthEase/Staywell Medicaid Preferred Drug List (PDL), effective May 15, 2014. Please carefully review these changes. Key UPPER CASE = Brand Name Drugs Lower case italics = Generic Drugs PDL = Preferred Drug List PA = Prior Authorization QL = Quantity Limits ST = Step Therapy Effective date of change: May 15, 2014 Drug Name Therapeutic Class Change PDL Alternative (if applicable) ADDITIONS TO THE PDL azurette tablets cyclafem 1/35 tablets cyclafem 7/7/7 tablets gildess 1.5/30 tablets gildess 1/20 tablets norethindrone 0.35 mg tablets norgestimate/ethinyl estradiol tablets nor-q-d tablets orsythia tablets zarah tablets Contraceptives Added to the PDL pilocarpine 2% ophthalmic drops Ophthalmic Agent; Miotic - Direct Acting Added to the PDL UTILIZATION MANAGEMENT CHANGES atorvastatin tablets 10 mg 40 mg 20 mg 80 mg CIPRODEX 0.3 - 0.1% otic suspension Antihyperlipidemic; HMG CoA Reductase Inhibitor Removed ST Otic Agent; Otic Steroid-AntiInfective Combination Updated AL: members ≤ 6 = covered; members > 6 = covered with ST (trial/failure of Ofloxacin 0.3% otic drops) Page 1 of 2 FL018136_PRO_LTR_ENG State Approve 03072012 ©WellCare 2012 FL_02_12 44181 Drug Name dextroamphetamine sulfate extended-release capsules Therapeutic Class Change Central Nervous System Agent; ADHD Agent, Amphetamine Updated AL: min: 6y, max: 20y; QL remains: 31 capsules /31 days; ST remains: trial/failure of Vyvanse or Adderall XR fluphenazine 2.5 mg /5 mL elixir Antipsychotic/Antim anic Agent; Phenothiazine Added AL: min 18y; QL remains (2480 mL/ 31 days) fluphenazine 5 mg /mL concentrate Antipsychotic/Antim anic Agent; Phenothiazine Added AL: min 18y; QL remains (248 mL/ 31 days) fluphenazine tablets 1 mg 5 mg 2.5 mg 10 mg Antipsychotic/Antim anic Agent; Phenothiazine Added AL: min 18y 5 mg 10 mg 15 mg PDL Alternative (if applicable) REMOVALS FROM THE PDL UNITHROID DIRECT 150 mcg tablets Thyroid Agent; Thyroid Hormone Removed from the PDL UNITHROID 150 mcg tablet VYTORIN tablets Antihyperlipidemic Combination; Intest Cholest Absorp Inhib - HMG CoA Reductase Inhib Comb Removed from the PDL simvastatin tablets ZETIA tablets 10/10 mg 10/40 mg 10/20 mg 10/80 mg If you have questions, HealthEase/Staywell Health Plan’s Pharmacy Help Desk and its affiliated vendor, Catamaran Rx, are available to assist providers seven days a week, 24 hours a day at 1877-647-7473. Thank you for your care of HealthEase/Staywell Medicaid members. Sincerely, HealthEase/Staywell Health Plans Page 2 of 2 FL018136_PRO_LTR_ENG State Approve 03072012 ©WellCare 2012 FL_02_12 44181
© Copyright 2026 Paperzz